Home Uncategorized It’s too early to tell whether CBD helps against Covid-19 — but...

It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers

262
0
SHARE

The scientists stressed the caveats that early-stage research demands: the compounds they had studied showed hints — in cells in lab dishes and in animals — of being able to combat the coronavirus. Definite answers could only come from clinical trials.

But the compounds were CBD and other marijuana and hemp derivatives, so the news took off. Kimmel and Colbert cracked jokes. The studies received coverage in outlets from Fox News to The Daily Beast.

The latest hubbub is an example of both the promise of cannabinoids — components of cannabis — as potential therapies, but also the hype around them, which can far outpace the evidence that they work. It’s left researchers and consumer advocates scrambling to warn people that patients shouldn’t be turning to over-the-counter products or recreational marijuana in hopes that it might protect them from Covid-19.

“We don’t want people running out taking random cannabinoids,” said Marsha Rosner of the University of Chicago, the senior author of one of the new studies.

The research also presents a new challenge for the Food and Drug Administration, which is already struggling to police the rapidly growing CBD market. While the agency has said CBD makers can’t market their products as medical treatments without conducting a clinical trial and submitting an application to the agency, few companies have actually invested in conducting those trials.  [Read More @ Stat News]

The post It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers appeared first on Cannabis Business Executive – Cannabis and Marijuana industry news.

See also  First Missouri medical marijuana dispensaries to start selling vape products Friday

LEAVE A REPLY

Please enter your comment!
Please enter your name here